EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
37 hedge funds and large institutions have $98.3M invested in ESSA Pharma in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
18% less funds holding
Funds holding: 45 → 37 (-8)
62% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 13
Holders
37
Holding in Top 10
–
Calls
$549K
Puts
$477K
Top Buyers
| 1 | +$3.26M | |
| 2 | +$2.47M | |
| 3 | +$942K | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$819K |
| 5 |
Millennium Management
New York
|
+$727K |
Top Sellers
| 1 | -$4.68M | |
| 2 | -$1.71M | |
| 3 | -$1.52M | |
| 4 |
D.E. Shaw & Co
New York
|
-$232K |
| 5 |
Two Sigma Investments
New York
|
-$125K |